Increased serum levels of vascular endothelial growth factor in patients with renal cell carcinoma

Japanese Journal of Cancer Research

Volumn 90, Issue 8, 1999, Pages 874-879

  Sato, Kazunari ^a   Tsuchiya, Norihiko ^a   Sasaki, Ryusei ^a   Shimoda, Naotake ^a   Satoh, Shigeru ^a   Ogawa, Osamu ^b   Kato, Tetsuro ^a  

^a AKITA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KYOTO UNIVERSITY GRADUATE SCHOOL OF MEDICINE   (Japan)

Author keywords

Renal cell carcinoma; Serum; VEGF

Indexed keywords

TUMOR MARKER; VASCULOTROPIN;

ADULT; AGED; ARTICLE; BLOOD LEVEL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMAN; KIDNEY CARCINOMA; KIDNEY VEIN; MALE; METASTASIS; NEPHRECTOMY; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; TUMOR VOLUME;

EID: 0032825449     PISSN: 09105050     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1349-7006.1999.tb00829.x     Document Type: Article

References (31)

1. Folkman, J. Tumor angiogenesis: therapeutic implications. N. Engl. J. Med., 285, 1182-1186 (1971).
2. Yoshino, S., Kato, M. and Okada, K. Prognostic significance of microvessel count in low stage renal cell carcinoma. Int. J. Urol., 2, 156-160 (1995).
3. Li, V. W., Folkerth, R. D., Watanabe, H., Yu, C., Rupnick, M., Barnes, P., Scott, R. M., Black, P. M., Sallan, S. E. and Folkman, J. Microvessel count and cerebrospinal fluid basic fibroblast growth factor in children with brain tumors. Lancet, 344, 82-86 (1994).
4. Takahashi, Y., Kitadai, Y., Bucana, C. D., Cleary, K. R. and Ellis, L. M. Expression of vascular endothelial growth factor and its receptor, KDR, correlates with vascularity, metastasis and proliferation. Cancer Res., 55, 3964-3968 (1995).
5. Weidner, N., Semple, J. P., Welch, W. R. and Folkman, J. Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma. N. Engl. J. Med., 32, 1-8 (1991).
6. Toi, M., Kashitani, J. and Tominaga, T. Tumor angiogenesis is an independent prognostic indicator in primary breast carcinoma. Int. J. Cancer, 55, 371-374 (1993).
7. Delahunt, B., Bethwaite, P. B. and Thornton, A. Prognostic significance of microscopic vascularity for clear cell renal cell carcinoma. Br. J. Urol., 80, 401-404 (1997).
8. Senger, D. R., Galli, S. J., Dvorak, A. M., Perruzzi, C. A., Harvey, V. S. and Dvorak, H. F. Tumor cells secrete a vascular permeability factor that promotes accumulation of ascites fluid. Science, 219, 983-985 (1983).
9. Plate, K. H., Breier, G., Weich, H. A., Mennel, H. D. and Risau, W. Vascular endothelial growth factor is a potential tumor angiogenesis factor in human gliomas in vivo. Nature, 356, 845-848 (1992).
10. Sato, K., Terada, K., Sugiyama, T., Takahashi, S., Saito, M., Moriyama, M., Kakinuma, H., Suzuki, Y., Kato, M. and Kato, T. Frequent overexpression of vascular endothelial growth factor in human renal cell carcinoma. Tohoku J. Exp. Med., 173, 355-360 (1994).
11. Takahashi, A., Sasaki, H., Kim, S. J., Tobisu, K., Kakizoe, T., Tsukamoto, T., Kumamoto, Y., Sugimura, T. and Terada, M. Markedly increased amount of messenger RNAs for endothelial growth factor and placenta growth factor in renal cell carcinoma associated with angiogenesis. Cancer Res., 54, 4233-4237 (1994).
12. Takano, S., Yoshii, Y., Kondo, S., Suzuki, H., Maruno, T., Shirai, S. and Nose, T. Concentration of vascular endothelial growth factor in the serum and tumor tissue of brain tumor patients. Cancer Res., 56, 2185-2190 (1996).
13. Toi, M., Kondo, S. and Suzuki, H. Quantitative analysis of vascular endothelial growth factor in primary breast cancer. Cancer, 77, 1101-1106 (1996).
14. Kondo, S., Asano, M. and Matsuo, K. Vascular endothelial growth factor/vascular permeability factor is detectable in the sera of tumor-bearing mice and cancer patients. Biochim. Biophys. Acta, 1221, 211-214 (1993).
15. Hermanek, P. and Sobin, L. H. ed. "UICC: TNM Classification of Malignant Tumors," 4th Ed., 2nd Rev. (1992). Springer-Verlag, Berlin.
16. Park, J. E., Keller, G. A. and Ferrara, N. The vascular endothelial growth factor (VEGF) isoforms: differential deposition into the subepithelial extracellular matrix and bioactivity of extracellular matrix-bound VEGF. Mol. Biol. Cell, 4, 1317-1326 (1993).
17. Kumar, H., Heer, K., Lee, P. W., Duthie, G. S., MacDonald, A. W., Greenman, J., Kerin, M. J. and Monson, J. R. Preoperative serum vascular endothelial growth factor can predict stage in colorectal cancer. Clin. Cancer Res., 4, 1279-1285 (1998).
18. Takigawa, N., Segawa, Y., Fujimoto, N., Hotta, K. and Eguchi, K. Elevated vascular endothelial growth factor levels in sera of patients with lung cancer. Anticancer Res., 18, 1251-1254 (1998).
19. Soker, S., Svahn, C. M. and Neufeld, G. Vascular endothelial growth factor is inactivated by binding to alpha 2-macroglobulin and the binding is inhibited by heparin. J. Biol. Chem., 268, 7685-7691 (1993).
20. Cohen, T., Nahari, D., Cerem, L. W., Neufeld, G. and Levi, B. Z. Interleukin 6 induces the expression of vascular endothelial growth factor. J. Biol. Chem., 271, 736-741 (1996).
21. Grad, S., Ertel, W., Keel, M., Infanger, M., Vonderschmitt, D. J. and Maly, F. E. Strongly enhanced serum levels of vascular endothelial growth. Clin. Chem. Lab. Med., 36, 379-383 (1997).
22. Torry, D. S. and Torry, R. J. Angiogenesis and the expression of vascular endothelial growth factor in endometrium and placenta. Am. J. Reprod. Immunol., 37, 21-29 (1998).
23. Sasaki, R. Microvessel count and vascular endothelial growth factor in renal cell carcinoma. Jpn. J. Urol., 87, 1032-1040 (1996).
24. Hyodo, I., Doi, T., Endo, H., Hosokawa, Y., Nishikawa, Y., Tanimizu, M., Jinno, K. and Kotani, Y. Clinical significance of plasma vascular endothelial growth factor in gastrointestinal cancer. Eur. J. Cancer, 34, 2041-2045 (1998).
25. Tempfer, C., Obermair, A., Hefler, L., Haeusler, G., Gitsch, G. and Kainz, C. Vascular endothelial growth factor serum concentrations in ovarian cancer. Obstet. Gynecol., 92, 360-363 (1998).
26. Fujimoto, K., Ichimori, Y., Yamaguchi, H., Arai, K., Futami, T., Ozono, S., Hirao, Y., Kakizoe, T., Terada, M. and Okajima, E. Basic fibroblast growth factor as a candidate tumor marker for renal cell carcinoma. Jpn. J. Cancer Res., 86, 182-186 (1995).
27. Sliutz, G., Tempfer, C., Obermair, A., Dadak, C. and Kainz, C. Serum evaluation of basic FGF in breast cancer patients. Anticancer Res., 15, 2675-2678 (1995).
28. Singh, R. K., Bucana, C. D., Gutman, M., Fan, D., Wilson, M. R. and Fidler, I. J. Organ site-dependent expression of basic fibroblast growth factor in human renal cell carcinoma cells. J. Am. Pathol., 145, 365-374 (1994).
29. Nanus, D. M., Schmitz-Draeger, B. J., Motzer, R. J., Lee, A. C., Vlamis, V., Cordon-Cardo, C., Albino, A. P. and Reuter, V. E. Expression of basic fibroblast growth factor in primary human renal tumours: correlation with poor survival. J. Natl. Cancer Inst., 85, 1597-1599 (1993).
30. Kato, T., Sato, K., Kakinuma, K. and Matsuda, Y. Enhanced suppression of tumor growth by combination of angiogenesis inhibitor O-(chloroacetyl-carbamoyl)fumagillol (TNP-470) and cytotoxic agents in mice. Cancer Res., 54, 5143-5147 (1994).
31. O'Reilly, M. S., Boehm, T., Shing, Y., Fukai, N., Vasios, G., Lane, W. S., Flynn, E., Birkhead, J. R., Olsen, B. R. and Folkman, J. Endostatin: an endogenous inhibitor of angiogenesis and tumor growth. Cell, 88, 277-285 (1997).